http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020501545-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020501545-A |
| titleOfInvention | RNA for treatment or prevention of liver disease |
| abstract | The present invention relates to RNA suitable for treating or preventing liver disease. In particular, the present invention relates to extracellular matrix protease, CCAAT / enhancer-binding protein α (CEBPA), TNF-related apoptosis-inducing ligand (TRAIL), hepatocyte growth factor (HGF), hepatocyte nuclear factor 4α (HNF4A), fibroblast At least one selected from the group consisting of growth factors, opioid growth factor receptor-like 1 (OGFRL1), relaxin 1 (RLN1), relaxin 2 (RLN2) and relaxin 3 (RLN3) An RNA encoding a peptide or protein is provided. The present invention relates to the above RNA, and compositions and kits containing the RNA. Furthermore, the invention relates to an RNA, a composition or a kit as disclosed herein, for use as a medicament, in particular for the treatment or prevention of liver disease. The invention also provides for the use of an RNA, composition or kit as disclosed herein to enhance expression of the encoded protein, especially in gene therapy. |
| priorityDate | 2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1509.